In summary, SLC27A2 overexpression inhibited ccRCC EMT in vitro while the knockdown of SLC27A2 in renal cancer cells promoted ccRCC EMT in vitro. The gene discussed is SLC27A2; the disease is nonpapillary renal cell carcinoma.